Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2010
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010127197A2 Method and composition for treating diabetic ketoacidosis
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010125910A1 Collagen peptide composition having good blood transfer properties, and food and drink containing same
11/04/2010WO2010125891A1 Estrogen-like agonist
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125390A1 Therapeutic agents 713
11/04/2010WO2010125330A1 Use of pufas to treat nerve damage
11/04/2010WO2010125136A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010124387A1 Bacterial compositions for prophylaxis and treatment of degenerative disease
11/04/2010WO2010124322A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010WO2010095808A3 Production method for astragalus membranaceus extract employing enzymolysis, and a composition for preventing or alleviating diabetes or obesity containing an active ingredient comprising an astragalus membranaceus extract produced by means of the production method
11/04/2010WO2010083207A3 Protein kinase c inhibitors and uses thereof
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280452 Medical devices having multiple layers
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280132 Method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
11/04/2010US20100280124 Acyl-urea derivatives and uses thereof
11/04/2010US20100280123 Food supplement containing alpha-keto acids for supporting diabetes therapy
11/04/2010US20100280115 Compositions of human lipids and methods of making and using same
11/04/2010US20100280109 Lipid compounds for use in cosmetic products, as food supplement or as a medicament
11/04/2010US20100280103 Methods and compositions for acid phosphatase-1 gene inhibition
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280067 Inhibitors of acetyl-coa carboxylase
11/04/2010US20100280060 Methods of screening and compositions for life span modulators
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280021 Pyridopyrimidine protein tyrosine phosphatase inhibitors
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280000 Therapeutic agents 713
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279979 Immunopotentiating agent for use in animals
11/04/2010US20100279962 Monosebacate of pyrazole derivative
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279944 Suppression and treatment of neuropathic pain
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279931 Insulin Derivative
11/04/2010US20100279930 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278941 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100278935 Immune System Modulator Formulation
11/04/2010US20100278924 Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
11/04/2010US20100278922 Methods and compositions for oral administration of insulin
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278879 Stable pharmaceutical composition and methods of using same
11/04/2010US20100278845 Melanocortin Receptor Binding Conjugates
11/04/2010US20100278843 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
11/04/2010US20100278823 Treatment of type 1 diabetes before and after expression of predisposition markers
11/04/2010US20100278810 Methods of Modulating Angiogenesis
11/04/2010US20100278804 Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders
11/04/2010US20100278796 Method for Improving the Digestibility and the Assimilability of Cereals and/or Fibres in a Monogastric Herbivorous Animal
11/04/2010US20100278795 Lactic acid bacterium-containing preparation
11/04/2010US20100278794 Agent for promoting the secretion of and/or suppressing decrease of adiponectin
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010US20100278760 Cosmetics
11/04/2010DE102009017966A1 Healthy liquid food/food supplement, useful e.g. in a dried plant extract, which is useful to prepare an infusion drink, comprises a sliced nettle leaf, sliced horsetail, speedwell herb and honey, in an aqueous solution
11/04/2010CA2762009A1 Use of pufas to treat nerve damage
11/04/2010CA2760525A1 Toll-like receptor 3 antagonists
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759795A1 Method and composition for treating diabetic ketoacidosis
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010CA2759494A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759491A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2759424A1 Collagen peptide composition having good ability to enter the blood and food or beverage containing the same
11/04/2010CA2759284A1 Stable pharmaceutical composition and methods of using same
11/04/2010CA2759230A1 Therapeutic agents 713
11/04/2010CA2759176A1 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246360A1 Compositions for the treatment of gastrointestinal disorders
11/03/2010EP2246347A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246047A1 Use of Lanostane derivatives in treating Cachexia
11/03/2010EP2245071A1 1d05 pcsk9 antagonists
11/03/2010EP2245070A1 1b20 pcsk9 antagonists
11/03/2010EP2245029A1 Heterocyclic inhibitors of stearoyl-coa desaturase
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 1298